When and How to Use Reversal Agents for Direct Oral Anticoagulants?

被引：0
作者：
Antonio Gómez-Outes
Mª Luisa Suárez-Gea
Ramón Lecumberri
机构：
[1] Agencia Española de Medicamentos y Productos Sanitarios (AEMPS),Division of Pharmacology and Clinical Drug Evaluation
[2] University Clinic of Navarra,Hematology Service
[3] Instituto de Salud Carlos III,Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV)
来源：
Current Cardiology Reports | 2023年 / 25卷
关键词：
Idarucizumab; Andexanet alfa; Prothrombin complex concentrates; Ciraparantag; VMX-C001; Anticoagulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：371 / 380
页数：9
相关论文
共 50 条
  • [21] Reversal Agents in Development for the New Oral Anticoagulants
    Costin, James
    Ansell, Jack
    Laulicht, Bryan
    Bakhru, Sasha
    Steiner, Solomon
    POSTGRADUATE MEDICINE, 2014, 126 (07) : 19 - 24
  • [22] New Reversal Agents for Oral Anticoagulants on the Horizon
    Mazur, Marcus D.
    Sivakumar, Walavan
    Taussky, Philipp
    Park, Min S.
    WORLD NEUROSURGERY, 2015, 84 (06) : 1506 - 1507
  • [23] Con: The Patient With Recent Intake of Direct Oral Anticoagulants-Problems Are Not Solved With the Approval of Reversal Agents
    Maegele, Marc
    Ntalouka, Maria
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2025, 39 (05) : 1348 - 1351
  • [24] Reversal of direct oral anticoagulants: a practical approach
    Shih, Andrew W.
    Crowther, Mark A.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, : 612 - 619
  • [25] Reversal of Direct Oral Anticoagulants: Current Status and Future Directions
    Weitz, Jeffrey I.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 38 (01) : 40 - 50
  • [26] Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants
    Gomez-Outes, Antonio
    Alcubilla, Pau
    Calvo-Rojas, Gonzalo
    Terleira-Fernandez, Ana Isabel
    Suarez-Gea, Luisa
    Lecumberri, Ramon
    Vargas-Castrillon, Emilio
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (24) : 2987 - 3001
  • [27] Reversal Agents for the New Generation of Oral Anticoagulants: Implications for the Perioperative Physician
    Lohrmann, Graham M.
    Atwal, Danish
    Augoustides, John G.
    Askar, Wajih
    Patel, Prakash A.
    Ghadimi, Kamrouz
    Makar, Gerges
    Gutsche, Jacob T.
    Shamoun, Fadi E.
    Ramakrishna, Harish
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2016, 30 (03) : 823 - 830
  • [28] Direct Oral Anticoagulant Agents: Pharmacologic Profile, Indications, Coagulation Monitoring, and Reversal Agents
    Rose, Deborah K.
    Bar, Barak
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (08) : 2049 - 2058
  • [29] How and when to measure anticoagulant effects of direct oral anticoagulants? Practical issues
    Tripodi, Armando
    Braham, Simon
    Scimeca, Barbara
    Moia, Marco
    Peyvandi, Flora
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (06): : 379 - 385
  • [30] Universal, class-specific and drug-specific reversal agents for the new oral anticoagulants
    Jack E. Ansell
    Journal of Thrombosis and Thrombolysis, 2016, 41 : 248 - 252
12345